Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women

Completed · Not applicable

Conditions studied: Osteoporosis, Bone Loss, Age Related, Postmenopausal Bone Loss, Postmenopausal Osteoporosis

In brief

To develop a decision aid to support the decision to use (or not use) bisphosphonates in postmenopausal women at risk for osteoporotic fractures, and to assess the impact of the decision aid on start and six month adherence to bisphosphonates.

Key facts

Study ID

NCT00578981

Run by

Mayo Clinic

People needed

100

Starts

2007-08-01

Expected to finish

2008-07-01

Last updated by the study team

2016-02-02

Who can join

Age: 50 and older, up to 90. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female, post-menopausal women aged 50 to 90.
• Have a bone mineral density (BMD) evaluation resulting in a T-Score of <-1.0.
• Have a follow-up appointment with a provider in the areas of Family Medicine (FM), Primary Care Internal Medicine (PCIM), or POM.
• Have no major barriers (i.e., severe hearing impairment, dementia, require interpreter, etc.) to participation in shared decision-making (per provider's assessment)
• Enrollment is open to females of diverse racial backgrounds.

You may not qualify if…

• Currently taking a bisphosphonate.
• Not available for 6 month follow-up phone call.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.